Arcline to acquire AstroNova for $272 million
AstroNova (NASDAQ:ALOT) agreed to be acquired by private equity firm Arcline Investment Management in an all-cash transaction with an enterprise value of approximately $272 million.
AstroNova (NASDAQ:ALOT) agreed to be acquired by private equity firm Arcline Investment Management in an all-cash transaction with an enterprise value of approximately $272 million.
Bed Bath & Beyond (NYSE:BBBY) signed a definitive agreement to acquire Fathom Holdings (NASDAQ:FTHM) to incorporate residential real estate services into its existing home-focused business model.
Diana Shipping (NYSE:DSX) — Genco's largest shareholder — states that its latest proposal offers Genco (NYSE:GNK) shareholders "immediate cash certainty" combined with the potential for equity participation in the combined company.
uniQure (NASDAQ:QURE) announced that the FDA cleared its clinical data package for AMT-130 to serve as the primary basis for a Biologics License Application (BLA).
Verastem Oncology (NASDAQ:VSTM) today announced positive updated safety and efficacy results from the RAMP 205 Phase 1b/2a Recommended Phase 2 Dose (RP2D) cohort of 29 patients evaluating its investigational combination regimen in first-line metastatic pancreatic ductal adenocarcinoma (PDAC).
Uber (NYSE:UBER), Nuro, and Lucid (NASDAQ:LCID) announced Houston as the second market for their joint robotaxi program.
Ian Lyngen, head of US rates strategy at BMO Capital Markets, discusses what to expect from the Federal Reserve's first policy decision under Chair Kevin Warsh. "The energy shock remains extremely topical for monetary policymakers and will probably ultimately drive the tone of what we hear from Warsh," he tells Bloomberg Television.
Jabil (NYSE:JBL) reported net revenue of $8.8 billion for its third quarter of fiscal year 2026, alongside U.S. GAAP operating income of $445 million.
Jazz Pharmaceuticals (NASDAQ:JAZZ) and AbCellera (NASDAQ:ABCL) executed a preclinical research collaboration to discover and develop T-cell engaging (TCE) multispecific antibodies.
Delta Air Lines (NYSE:DAL) will install Vortex Control Technologies aerodynamic finlets across 240 of its Boeing 737 aircraft to reduce operational emissions.